Oncology Today with Dr Neil Love cover image

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Oncology Today with Dr Neil Love

00:00

EMBER-3 and Imlunestrant Approval

Rinath summarizes EMBER-3 showing imlunestrant improved PFS in ESR1-mutant patients and details trial endpoints and subgroups.

Play episode from 24:19
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app